Section Arrow
Quote
AMRX.NASDAQ
- Amneal Pharmaceuticals
Quotes are at least 15-min delayed:2026/11/14 14:24 EST
Regular Hours
Last
 21.38
-0.32 (-1.47%)
Day High 
21.72 
Prev. Close
21.7 
1-M High
22.0652 
Volume 
1.72M 
Bid
21
Ask
21.74
Day Low
21.3 
Open
21.485 
1-M Low
18.785 
Market Cap 
7.56B 
Currency 美元 
P/E 54.25 
%Yield -- 
10-SMA 20.78 
20-SMA 20.61 
50-SMA 19.64 
52-W High 22.0652 
52-W Low 11.39 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.40/1.17
Enterprise Value
10.23B
Balance Sheet
Book Value Per Share
1.52
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
2.79B
Operating Revenue Per Share
6.64
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.